Current surgical management of rectal cancer

Digestive Surgery

Volumn 24, Issue 2, 2007, Pages 115-119

  Kusunoki, Masato ^a   Inoue, Yasuhiro ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Lymph node dissection, lateral; Mesorectal excision, total; Rectal cancer

Indexed keywords

UFT;

ADVANCED CANCER; ANUS SPHINCTER; AUTONOMIC NERVE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; EXCISION; GOLD STANDARD; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MORBIDITY; PROGNOSIS; QUALITY OF LIFE; RECTUM CANCER; RECTUM RESECTION; REVIEW; SURGICAL ANATOMY; SURGICAL TECHNIQUE; TOTAL MESORECTAL EXCISION; TREATMENT OUTCOME; UROGENITAL SYSTEM;

HUMANS; JAPAN; LYMPH NODE EXCISION; RECTAL NEOPLASMS;

EID: 34249030616     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101898     Document Type: Review

References (37)

1. Glimelius B, Isacsson U, Jung B, Pahlman L: Radiotherapy in addition to radical surgery in rectal cancer. Acta Oncol 1995;34:565-570.
2. Gastrointestinal Tumor Study Group: Adjuvant therapy of colon cancer: results of a prospectively randomized trial. N Engl Med 1984;310:737-743.
3. Heald RJ, Husband EM, Ryall RD: The mesorectum in rectal cancer surgery - the clue to pelvic recurrence? Br J Surg 1982;69:613-616.
4. Heald RJ, Ryall RD: Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;i:1479-1482.
5. Miles WE: A method of performing abdomino-peritoneal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet 1908;ii:1812-1813.
6. Williams NS, Durdey P, Johnston D: The outcome following sphincter-saving resection and abdominoperineal resection for low rectal cancer. Br J Surg 1985;72:595-598.
7. Pollett WG, Nicholls RJ: The relationship between the extent of distal clearance and survival and local recurrence rates after curative anterior resection for carcinoma of the rectum. Ann Surg 1983;198:159-163.
8. MacFarlane JK, Ryall RD, Heald RJ: Mesorectal excision for rectal cancer. Lancet 1993;341:457-60.
9. Enker WE: Potency, cure, and local control in the operative treatment of rectal cancer. Arch Surg 1992;127:1396-1401.
10. Lowry AC, Simmang CL, Boulos P, Farmer KC, Finan PJ, Hyman N, Killingback M, Lubowski DZ, Moore R, Penfold C, Savoca P, Stitz R, Tjandra JJ: Consensus statement of definitions for anorectal physiology and rectal cancer: report of the Tripartite Consensus Conference on Definitions for Anorectal Physiology and Rectal Cancer, Washington, DC, May 1, 1999. Dis Colon Rectum 2001;44:915-919.
11. Morikawa E, Yasutomi M, Shindou K, Matsuda T, Mori N, Hida J, Kubo R, Kitaoka M, Nakamura M, Fujimoto K, et al: Distribution of metastatic lymph nodes in colorectal cancer by the modified clearing method. Dis Colon Rectum 1994;37:219-223.
12. Hida J, Yasutomi M, Fujimoto K, Maruyama T, Okuno K, Shindo K: Does lateral lymph node dissection improve survival in rectal carcinoma? Examination of node metastases by the clearing method. J Am Coll Surg 1997;184:475-480.
13. Yamakoshi H, Ike H, Oki S, Hara M, Shimada H: Metastasis of rectal cancer to lymph nodes and tissues around the autonomic nerves spared for urinary and sexual function. Dis Colon Rectum 1997;40:1079-1084.
14. Moriya Y, Sugihara K, Akasu T, Fujita S: Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J Surg 1997;21:728-732.
15. Takahashi T, Ueno M, Azekura K, Ohta H: Lateral node dissection and total mesorectal excision for rectal cancer. Dis Colon Rectum 2000;43:S59-S68.
16. Ueno M, Oya M, Azekura K, Yamaguchi T, Muto T: Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg 2005;92:756-763.
17. Morita T, Murata A, Koyama M, Totsuka E, Sasaki M: Current status of autonomic nerve-preserving surgery for mid and lower rectal cancers: Japanese experience with lateral node dissection. Dis Colon Rectum 2003;46:S78-S87.
18. Fujita S, Yamamoto S, Akasu T, Moriya Y: Lateral pelvic lymph node dissection for advanced lower rectal cancer. Br J Surg 2003;90:1580-1585.
19. Hojo K, Koyama Y, Moriya Y: Lymphatic spread and its prognostic value in patients with rectal cancer. Am J Surg 1982;144:350-354.
20. Mori T, Takahashi K, Yasuno M: Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissection. Langenbecks Arch Surg 1998;383:409-415.
21. Hojo K, Sawada T, Moriya Y: An analysis of survival and voiding, sexual function after wide iliopelvic lymphadenectomy in patients with carcinoma of the rectum, compared with conventional lymphadenectomy. Dis Colon Rectum 1989;32:128-133.
22. Fengler SA, Pearl RK: Technical considerations in the surgical treatment of colon and rectal cancer. Semin Surg Oncol 1994;10:200-207.
23. Bruch HP, Schwandner O, Schiedeck TH, Roblick UJ: Actual standards and controversies on operative technique and lymph-node dissection in colorectal cancer. Langenbecks Arch Surg 1999;384:167-175.
24. Sugihara K, Moriya Y, Akasu T, Fujita S: Pelvic autonomic nerve preservation for patients with rectal carcinoma. Oncologic and functional outcome. Cancer 1996;78:1871-1880.
25. Maeda K, Maruta M, Utsumi T, Sato H, Toyama K, Matsuoka H: Bladder and male sexual functions after autonomic nervesparing TME with or without lateral node dissection for rectal cancer. Tech Coloproctol 2003;7:29-33.
26. Ueno H, Mochizuki H, Hashiguchi Y, Hase K: Prognostic determinants of patients with lateral nodal involvement by rectal cancer. Ann Surg 2001;234:190-197.
27. Ueno H, Mochizuki H, Shinto E, Hashiguchi Y, Hase K, Talbot IC: Histologic indices in biopsy specimens for estimating the probability of extended local spread in patients with rectal carcinoma. Cancer 2002;94:2882-2891.
28. Ueno H, Mochizuki H, Fujimoto H, Hase K, Ichikura T: Autonomic nerve plexus involvement and prognosis in patients with rectal cancer. Br J Surg 2000;87:92-96.
29. Matsumoto T, Ohue M, Sekimoto M, Yamamoto H, Ikeda M, Monden M: Feasibility of autonomic nerve-preserving surgery for advanced rectal cancer based on analysis of micrometastases. Br J Surg 2005;92:1444-1448.
30. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ; Dutch Colorectal Cancer Group: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-646.
31. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R;German Rectal Cancer Study Group: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740.
32. Watanabe T, Tsurita G, Muto T, Sawada T, Sunouchi K, Higuchi Y, Komuro Y, Kanazawa T, Iijima T, Miyaki M, Nagawa H: Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers. Surgery 2002;132:27-33.
33. Nagawa H, Muto T, Sunouchi K, Higuchi Y, Tsurita G, Watanabe T, Sawada T: Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 2001;44:1274-1280.
34. Kato T, Ohashi Y, Nakazato H, Koike A, Saji S, Suzuki H, Takagi H, Nimura Y, Hasumi A, Baba S, Manabe T, Maruta M, Miura K, Yamaguchi A: Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial. Langenbecks Arch Surg 2002;386:575-581.
35. Kusunoki M, Yanagi H, Kotera H, Noda M, Yamamura T: Effects of pharmacokinetic modulating chemotherapy using oral UFT and continuous venous 5FU infusion on the prognosis of irradiated rectal carcinomas with p53 overexpression. Int J Oncol 1998;13:653-657.
36. Akasu T, Moriya Y, Ohashi Y, Yoshida S, Shirao K, Kodaira S; National Surgical Adjuvant Study of Colorectal Cancer: Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial. Jpn J Clin Oncol 2006;36:237-244.
37. Havenga K, Enker WE, Norstein J, Moriya Y, Heald RJ, van Houwelingen HC, van de Velde CJ: Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1,411 patients. Eur J Surg Oncol 1999;25:368-374.